1-3 of 3
Matthew McGinniss, PhD
Close
Sort by
Journal Articles

Somatic Mutations Indicative of Clonal Hematopoiesis Are Present in a Large Fraction of Cytopenic Patients Who Lack Diagnostic Evidence of MDS

Jeff Hall, PhD, Jenan Al Hafidh, PhD, Emily Balmert, Bashar Dabbas, MD, Christine Vaupel, PhD, Carlos El Hader, PhD, Matthew McGinniss, PhD, Sue Beruti, MD, Rafael Bejar, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3272.
https://doi.org/10.1182/blood.V124.21.3272.3272
Published: 2014
Journal Articles

Next-Generation Sequencing (NGS)-Based Profiling of Idiopathic Cytopenia of Undetermined Significance (ICUS) Identifies a Subset of Patients with Genomic Similarities to Lower-Risk Myelodysplastic Syndrome (MDS)

Brian Kwok, MD, Prashanti Reddy, MD, Keming Lin, MD, Rachel Flamholz, MD, Aine Yung, MD, Bashar Dabbas, MD, Matthew McGinniss, PhD, Shareef Nahas, PhD, Julie Kines, Yin Xu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 166.
https://doi.org/10.1182/blood.V124.21.166.166
Published: 2014
Journal Articles

Next-Generation Sequencing Of ASXL1, TP53, RUNX1, EZH2, and ETV6 Identifies a Significant Proportion Of Lower-Risk Myelodysplastic Syndromes With Poor Prognostic Indicators

Brian Kwok, MD, Renee Mohrmann, MD, Kim Janatpour, MD, Yin Xu, MD, PhD, Matthew McGinniss, PhD, Aine Yung, MD, Hong Drum, MD, Keming Lin, MD, Julie Kines, Jeffrey Tasmin, Bashar Dabbas, MD
Journal: Blood
Blood (2013) 122 (21): 1552.
https://doi.org/10.1182/blood.V122.21.1552.1552
Published: 2013